Skip to content

Transcription, RNA Processing and Non-coding RNA

RNA polymerases, promoters, inhibitors, activators and repressors, capping, splicing, editing, polyadenylation, RNA export, ribozymes, riboswitches and ncRNA.

  • 23 min read
  • Updated
On this page · 17 sections
  1. Prerequisites
  2. The Hook: A Mushroom, an Antibiotic and Three Polymerases
  3. Bacterial Transcription
  4. Eukaryotic Transcription
  5. Processing of Pre-mRNA
  6. Processing of rRNA and tRNA
  7. RNA Transport
  8. Ribozymes
  9. Riboswitches
  10. Non-coding RNA
  11. Memory Tricks
  12. Don’t Confuse
  13. Common Mistakes
  14. Practice
  15. Quick Revision Table
  16. Key Takeaways
  17. What’s Next

Prerequisites

The Hook: A Mushroom, an Antibiotic and Three Polymerases


Bacterial Transcription

RNA polymerase

E. coli has a single RNA polymerase. The core enzyme is α₂ββ’ω: β’ binds DNA, β contains the active site with β’ and binds rifampicin, the α subunits assemble the enzyme and their C-terminal domains (αCTD) contact activators and the UP element. Adding a σ factor gives the holoenzyme, which recognises promoters. σ is released (or loosened) after initiation and recycled.

σ factorGenesPromoter / note
σ⁷⁰ (RpoD)Housekeeping−35 TTGACA, −10 TATAAT (Pribnow box), spacer optimally 17 bp
σ³² (RpoH)Heat shockDifferent −35/−10 consensus
σ⁵⁴ (RpoN)Nitrogen assimilation and others−24/−12 elements; needs an ATP-hydrolysing enhancer-binding activator (e.g. NtrC) acting from a distance through DNA looping, like a eukaryotic enhancer
σˢ (RpoS, σ³⁸)Stationary phase, general stress
σ²⁸ (FliA)Flagellar genes
σᴱ (σ²⁴)Envelope (extracytoplasmic) stressHeld by an anti-σ factor in the membrane

The transcription cycle

  1. Closed complex: holoenzyme binds the −35 and −10 elements.
  2. Open complex: about 12–14 bp around the −10 region melt (the transcription bubble); no ATP is needed for melting.
  3. Abortive initiation: short transcripts (2–10 nt) are made and released repeatedly while the polymerase stays at the promoter, pulling downstream DNA into itself (scrunching).
  4. Promoter escape: once the RNA is about 10 nt long, σ contacts are broken and the elongation complex leaves.
  5. Elongation: the RNA–DNA hybrid in the bubble is about 8–9 bp; the polymerase moves at a few tens of nucleotides per second and can backtrack and cleave (GreA/GreB). NusA and NusG modulate pausing.
  6. Termination:
    • Intrinsic (Rho-independent): a GC-rich inverted repeat forms a hairpin in the RNA, followed by a run of U residues; the weak rU·dA hybrid lets the RNA dissociate.
    • Rho-dependent: Rho, a hexameric RNA–DNA helicase with ATPase activity, binds a C-rich, unstructured rut site on the RNA, translocates 5’ → 3’ and pulls the RNA off a paused polymerase. Rho cannot load where ribosomes are translating, which links termination to translation (polarity).

Promoter strength depends on how close −35 and −10 are to consensus, spacer length, and the presence of an AT-rich UP element upstream of −35 (bound by αCTD). Mutations that move a promoter towards consensus are up-promoter mutations; those away from it are down-promoter mutations.

Inhibitors of transcription

InhibitorTargetEffect
RifampicinBacterial RNA polymerase β subunit, in the channel next to the active site, blocking the path of the growing RNABlocks extension beyond 2–3 nt, so it inhibits initiation; an elongating polymerase is resistant
StreptolydiginBacterial β'Blocks elongation
FidaxomicinBacterial RNAP “switch region”Blocks open complex formation
Actinomycin DDNA (intercalates at G·C pairs)Blocks elongation by all polymerases, bacterial and eukaryotic; low doses preferentially block Pol I (rRNA)
α-AmanitinLargest subunit of eukaryotic Pol II (near the bridge helix)Pol II very sensitive, Pol III moderately, Pol I resistant (animal cells)
Cordycepin (3’-deoxyadenosine)Incorporated as 3’-dATPChain termination; also blocks poly(A) addition
DRB, flavopiridolCDK9 of P-TEFbBlock Pol II pause release and productive elongation
TriptolideXPB subunit of TFIIHBlocks Pol II initiation

Eukaryotic Transcription

Three nuclear RNA polymerases (and two plant-specific ones)

PolymeraseProductsα-AmanitinLocation
Pol ILarge rRNA precursor (45S/47S in mammals → 18S, 5.8S, 28S)ResistantNucleolus
Pol IImRNA, most snRNAs (U1, U2, U4, U5), miRNA precursors, most lncRNAsVery sensitiveNucleoplasm
Pol IIItRNA, 5S rRNA, U6 snRNA, 7SL RNA (SRP), 7SK RNAModerately sensitiveNucleoplasm
Pol IV, Pol V (plants)siRNA precursors and scaffold transcripts for RNA-directed DNA methylation

Pol III promoters are unusual: tRNA genes use internal promoters (A and B boxes inside the gene), 5S rRNA uses an internal control region bound by TFIIIA, and U6 uses an upstream, Pol II-like promoter with a TATA box.

The Pol II core promoter and general transcription factors

Core promoter elements: TATA box (consensus TATAAA, about 25–30 bp upstream of the start site), Inr (initiator, spanning the start site), DPE (downstream promoter element), BRE (TFIIB recognition element). Many genes, especially housekeeping genes with CpG islands, lack a TATA box.

FactorFunction
TFIIDTBP (TATA-binding protein, binds the minor groove and bends DNA sharply) + TAFs (recognise Inr, DPE)
TFIIAStabilises TBP–DNA
TFIIBBridges TBP and Pol II; sets the start site
TFIIFBrings Pol II to the promoter
TFIIERecruits TFIIH
TFIIHXPB helicase/ATPase opens the promoter; CDK7 kinase phosphorylates the CTD at Ser5 (also an NER factor)

Assembly order (textbook): TFIID → TFIIA → TFIIB → Pol II·TFIIF → TFIIE → TFIIH. Unlike bacterial open-complex formation, Pol II promoter opening needs ATP (TFIIH).

The CTD code

The C-terminal domain of the Pol II largest subunit has many repeats of the heptad Tyr-Ser-Pro-Thr-Ser-Pro-Ser (YSPTSPS).

graph LR
    A["Unphosphorylated CTD
Pol II joins the
preinitiation complex"] --> B["Ser5-P (TFIIH/CDK7)
initiation, promoter escape,
capping enzymes recruited"] B --> C["Promoter-proximal pause
(DSIF, NELF)"] C --> D["P-TEFb (CDK9) phosphorylates
Ser2, DSIF, NELF
productive elongation"] D --> E["Ser2-P high at 3' end
splicing and cleavage/
polyadenylation factors"]

The CTD is the platform that couples transcription to capping, splicing and 3’ end formation. Pol I and Pol III have no CTD, and their products do not receive the m⁷G cap or a poly(A) tail.

Activators, repressors and the Mediator

Gene-specific regulators bind proximal promoter elements (GC box, CAAT box) and enhancers that can be thousands of base pairs away, upstream, downstream or in introns, in either orientation.

  • Activators are modular: a DNA-binding domain (helix-turn-helix, homeodomain, zinc finger, basic leucine zipper, basic helix-loop-helix) plus an activation domain (acidic, glutamine-rich or proline-rich). Domain-swap experiments, for example the yeast Gal4 DNA-binding domain fused to another protein’s activation domain, show the two can be separated, which is the basis of the yeast two-hybrid assay.
  • Activators work by recruiting Mediator (which contacts Pol II), general factors, and co-activators that modify chromatin (HATs such as CBP/p300, and ATP-dependent remodellers).
  • Repressors compete with activators for binding, mask activation domains, block GTF assembly, or recruit co-repressors (HDACs, histone methyltransferases).
  • Insulators (bound by CTCF in vertebrates) block enhancer–promoter communication across them and act as barriers to heterochromatin spread.

The detailed operon and eukaryotic regulatory circuits are on the regulation page.

Termination by the eukaryotic polymerases

  • Pol I: a termination factor bound downstream of the rRNA unit.
  • Pol III: a short run of T residues in the non-template strand; no hairpin needed.
  • Pol II: coupled to cleavage and polyadenylation. In the torpedo model, the 5’→3’ exonuclease Xrn2 degrades the downstream RNA left attached to Pol II after cleavage, catches up and dislodges the polymerase; in the allosteric model, passing the poly(A) signal changes Pol II and its associated factors so it becomes termination-prone. Both contribute.

Processing of Pre-mRNA

5’ capping

Happens co-transcriptionally, very early (once the RNA is a few tens of nucleotides long and emerges from Pol II with Ser5-P CTD).

  1. RNA triphosphatase removes the γ-phosphate of the first nucleotide.
  2. Guanylyltransferase adds GMP (from GTP) in an unusual 5’–5’ triphosphate linkage.
  3. Guanine-N7 methyltransferase methylates the G with S-adenosylmethionine → cap 0 (m⁷GpppN).
  4. 2’-O-methylation of the first (cap 1) and second (cap 2) transcribed nucleotides in higher eukaryotes.

Functions: protects from 5’ exonucleases, binds the nuclear cap-binding complex (CBC: CBP80/CBP20) for splicing of the first intron and export, and binds eIF4E in the cytoplasm for translation initiation.

Splicing

Splice-site signals in a nuclear pre-mRNA intron:

  • 5’ splice site: exon…AG|GURAGU…
  • Branch point: an A typically 18–40 nt upstream of the 3’ splice site (yeast consensus UACUAAC)
  • Polypyrimidine tract
  • 3’ splice site: …YAG|exon

(GU–AG rule; a minor class uses AU–AC and other dinucleotides.)

Chemistry: two transesterifications

  1. The 2’-OH of the branch-point A attacks the phosphate at the 5’ splice site → exon 1 with a free 3’-OH + a lariat intermediate (the intron’s 5’ G joined to the branch A by a 2’–5’ phosphodiester; the branch A has three phosphodiester bonds).
  2. The 3’-OH of exon 1 attacks the phosphate at the 3’ splice site → ligated exons + released lariat intron (debranched and degraded).

The number of phosphodiester bonds is unchanged, so the chemistry needs no energy input; ATP is used by the DExD/H-box helicases that rearrange the spliceosome.

The spliceosome

snRNPRole
U1Base-pairs with the 5’ splice site (E complex)
U2Base-pairs with the branch site, bulging the branch A (A complex; ATP)
U2AF (protein, not an snRNP)U2AF65 binds the polypyrimidine tract, U2AF35 the 3’ AG; SF1/BBP binds the branch point
U4/U6·U5 tri-snRNPJoins (B complex); U4 is released and U6 displaces U1 at the 5’ splice site and pairs with U2
U5Aligns the two exons for the second step
U2–U6Form the catalytic RNA core with Mg²⁺ ions: the spliceosome is a ribozyme

The minor (U12-type) spliceosome uses U11, U12, U4atac, U6atac with U5.

Self-splicing introns

TypeNucleophile for step 1ProductExamples
Group I3’-OH of an exogenous guanosine (G, GMP, GDP or GTP)Linear intronTetrahymena pre-rRNA, some organelle and phage genes
Group II2’-OH of an internal branch-point ALariatOrganelle genes in fungi and plants; mechanistically like the spliceosome
Nuclear pre-mRNA2’-OH of branch ALariatNeeds the spliceosome
Pre-tRNA (eukaryotic)Protein enzymes: endonuclease + ligaseIntrons next to the anticodon

Alternative splicing (exon skipping, mutually exclusive exons, alternative 5’ or 3’ sites, intron retention) is regulated by SR proteins binding exonic splicing enhancers (usually promoting use of a site) and hnRNPs binding splicing silencers (usually repressing). Classic examples: Drosophila sex determination (Sex-lethal regulates transformer splicing; Tra and Tra2 regulate doublesex), and Drosophila Dscam, whose four clusters of alternative exons can in principle generate tens of thousands of isoforms. Splicing also deposits the exon junction complex (EJC) about 20–24 nt upstream of each exon–exon junction, which marks the mRNA for export and for nonsense-mediated decay (NMD): a stop codon more than about 50–55 nt upstream of the last exon junction is recognised as premature, and UPF proteins trigger decay.

RNA editing

A change in the RNA sequence after transcription, other than splicing and end processing.

TypeEnzymeClassic exampleResult
C → U deaminationAPOBEC1 (with a cofactor)Apolipoprotein B mRNA in the intestine: a CAA (Gln) codon becomes UAA (stop)Intestine makes the truncated apoB-48; liver makes full-length apoB-100 from the same gene
A → I deaminationADAR (acts on dsRNA)AMPA glutamate receptor subunit GluA2 (GluR-B) Q/R site: CAG → CIG, read as CGG (Arg)Receptor channel becomes Ca²⁺-impermeable. Inosine is read as G
U insertion/deletionGuide RNA-directed editosomeTrypanosome mitochondrial (kinetoplastid) mRNAsMany Us inserted or deleted to create reading frames
C → U in organellesPlant mitochondria and chloroplastsOften restores conserved codons

3’ end formation and polyadenylation

  • Signal: AAUAAA about 10–30 nt upstream of the cleavage site, and a GU- or U-rich element downstream.
  • CPSF binds AAUAAA (its CPSF-73 subunit is the endonuclease); CstF binds the GU-rich element; CFI and CFII assist; the CTD helps recruit them.
  • Cleavage, then poly(A) polymerase (PAP) adds A residues (template-independent, ATP as substrate); nuclear poly(A)-binding protein (PABPN1) stimulates PAP and helps set the tail length (around 200–250 A in mammals).
  • Cytoplasmic PABPC binds the tail, protects the mRNA and interacts with eIF4G (closed-loop translation).
  • Exception: replication-dependent histone mRNAs are not polyadenylated; their 3’ end is a stem-loop bound by SLBP, made by U7 snRNP-directed cleavage.
  • Alternative polyadenylation gives mRNAs with different 3’ UTRs (and so different miRNA sites and stabilities), or even different C-termini.

mRNA decay

Most cytoplasmic mRNAs are degraded by deadenylation (CCR4–NOT, PAN2–PAN3) followed by decapping (Dcp2) and 5’ → 3’ degradation by Xrn1, or by 3’ → 5’ degradation by the exosome. AU-rich elements (AUUUA repeats) in 3’ UTRs of cytokine and proto-oncogene mRNAs cause rapid decay.


Processing of rRNA and tRNA

  • Bacteria: rRNA operons give a single precursor (16S, 23S, 5S and often tRNAs); RNase III cuts in double-stranded stems, then other nucleases trim.
  • Eukaryotes: Pol I makes one precursor containing 18S, 5.8S and 28S (the 5S is made separately by Pol III); processing happens in the nucleolus, guided by snoRNAs: box C/D snoRNAs guide 2’-O-methylation, box H/ACA snoRNAs guide pseudouridylation.
  • tRNA: RNase P (a ribozyme) cuts the 5’ leader; 3’ trailer removed by endonuclease/exonucleases; CCA added by tRNA nucleotidyltransferase if not encoded; many base modifications (dihydrouridine, pseudouridine, inosine at the wobble position in some tRNAs); some eukaryotic pre-tRNAs have introns removed by protein enzymes.

RNA Transport

All RNAs made in the nucleus must cross the nuclear pore complex.

RNAExport receptorRan-GTP dependent?
Bulk mRNANXF1–NXT1 (yeast Mex67–Mtr2), loaded by the TREX complex coupled to capping, splicing and 3’ processingNo; directionality from the cytoplasmic DEAD-box ATPase Dbp5/DDX19, which remodels the mRNP at the cytoplasmic face
tRNAExportin-tYes
pre-miRNAExportin-5Yes
Some snRNAs, rRNA subunits, unspliced HIV RNA (via Rev)CRM1 (exportin-1) recognising leucine-rich nuclear export signalsYes

Pre-mRNAs with unspliced introns are normally retained in the nucleus. HIV overcomes this with the Rev protein, which binds the Rev response element (RRE) in its unspliced and partly spliced RNAs and recruits CRM1. Cytoplasmic mRNA localisation (for example ASH1 mRNA to the yeast bud tip, bicoid to the anterior of the Drosophila oocyte) uses 3’ UTR “zipcode” sequences and motor proteins.


Ribozymes

Catalytic RNAs. Discovered through the self-splicing Tetrahymena rRNA intron (Cech) and the RNA subunit of RNase P (Altman); the two shared the 1989 Nobel Prize in Chemistry.

RibozymeReaction
Group I and group II intronsSelf-splicing by transesterification
RNase P RNA (M1 RNA in E. coli)Cuts the 5’ leader of pre-tRNA; the RNA alone is catalytic in vitro at high Mg²⁺
Hammerhead, hairpin, HDV ribozymesSelf-cleavage, producing a 2’,3’-cyclic phosphate and a 5’-OH; used in rolling-circle replication of viroids and satellite RNAs
Peptidyl transferase centre of the large-subunit rRNA (23S/28S)Peptide bond formation; no protein within the immediate active site
Spliceosome (U2–U6 core)Pre-mRNA splicing
glmS ribozymeSelf-cleaves when glucosamine-6-phosphate binds (also a riboswitch)

RNA can catalyse because it folds into defined 3D structures, its 2’-OH can act as a nucleophile and its phosphates bind Mg²⁺ ions that stabilise transition states. This underlies the RNA world hypothesis.


Riboswitches

Structured elements, mostly in the 5’ UTRs of bacterial mRNAs, that bind a small metabolite directly, without any protein, and change gene expression.

  • Aptamer domain: binds the ligand with high specificity.
  • Expression platform: switches structure on binding.
MechanismHow
Transcription terminationLigand binding favours a terminator hairpin over an antiterminator (or the reverse)
Translation initiationLigand binding sequesters (or exposes) the Shine–Dalgarno sequence
Self-cleavageglmS ribozyme cleaves its own mRNA on GlcN6P binding
Splicing / 3’ processingTPP riboswitches in fungi and plants control alternative splicing or polyadenylation

Ligands include TPP, FMN, SAM, lysine, glycine (tandem aptamers), guanine and adenine, cobalamin and others. Most riboswitches are “off” switches that repress the genes for making the ligand when it is abundant: feedback without a protein repressor.


Non-coding RNA

graph TD
    N["Non-coding RNA"] --> H["Housekeeping
rRNA, tRNA, snRNA,
snoRNA, RNase P, SRP 7SL,
telomerase RNA"] N --> S["Small regulatory
miRNA, siRNA, piRNA;
bacterial sRNA"] N --> L["Long non-coding
Xist, HOTAIR, MALAT1,
NEAT1, 7SK, enhancer RNAs"]

miRNA, siRNA and piRNA

FeaturemiRNAsiRNApiRNA
SourceEndogenous hairpin transcripts (Pol II)Long dsRNA (viral, transgene, repeat)Single-stranded precursors from piRNA clusters
ProcessingDrosha–DGCR8 (nucleus) → pre-miRNA → Exportin-5 → Dicer (cytoplasm)DicerDicer-independent; ping-pong amplification
LengthAbout 21–23 ntAbout 21–23 ntLonger (about 24–31 nt), 2’-O-methylated 3’ end
EffectorArgonaute (AGO) in RISCAGO2 (slicer)PIWI proteins
Target pairingAnimals: seed (nt 2–8) with partial complementarity in 3’ UTRs → translational repression, deadenylation and decay. Plants: near-perfect → cleavagePerfect → cleavage of targetTransposon transcripts
Main roleFine-tuning hundreds of genesAntiviral defence, experimental knockdownTransposon silencing in the germline

The first miRNA, lin-4, was found in C. elegans developmental timing; Victor Ambros and Gary Ruvkun received the 2024 Nobel Prize in Physiology or Medicine for the discovery of microRNA. RNA interference by dsRNA in C. elegans was reported by Fire and Mello (Nobel Prize 2006).

Other ncRNAs worth knowing

  • Bacterial sRNAs: base-pair with target mRNAs, helped by the chaperone Hfq; for example RyhB (iron starvation) represses iron-using proteins, MicF represses the porin OmpF. 6S RNA mimics an open promoter and sequesters σ⁷⁰ holoenzyme in stationary phase. tmRNA rescues stalled ribosomes (see the translation page). CRISPR RNAs guide Cas nucleases.
  • lncRNAs (longer than 200 nt): Xist coats the inactive X and recruits silencing complexes; HOTAIR (from the HOXC locus) represses HOXD genes in trans via PRC2; 7SK sequesters P-TEFb; MALAT1 and NEAT1 organise nuclear speckles and paraspeckles. Mechanisms: guides, scaffolds, decoys, and enhancer RNAs.
  • snoRNAs (modification guides) and scaRNAs (Cajal body, snRNA modification).

Memory Tricks

Don’t Confuse

ThisvsThat
Rifampicin: binds RNAP β, blocks initiationvsActinomycin D: binds DNA, blocks elongation in all cells
Rho-independent: hairpin + U-runvsRho-dependent: C-rich rut site, ATP-driven helicase
σ⁷⁰: promoter melting without ATPvsσ⁵⁴: needs an ATP-hydrolysing enhancer-binding activator
TFIIH CDK7: Ser5-P (initiation)vsP-TEFb CDK9: Ser2-P (elongation)
Group I intron: exogenous G, linear intronvsGroup II intron: internal A, lariat
Cap: 5’–5’ triphosphate, m⁷GvsLariat: 2’–5’ phosphodiester at branch A
CPSF: binds AAUAAAvsCstF: binds downstream GU-rich element
mRNA export: NXF1, Ran-independentvstRNA/pre-miRNA export: exportins, Ran-GTP-dependent
Ribozyme: RNA catalyses a reactionvsRiboswitch: RNA binds a metabolite to regulate a gene
miRNA: hairpin, seed pairing, repressionvssiRNA: long dsRNA, perfect pairing, cleavage

Common Mistakes


Practice

All questions below are original practice questions written in CSIR NET style. They are not previous-year questions.

Level 1: Foundation

  1. Which snRNA base-pairs with the 5’ splice site first?
  2. What is the consensus −10 element of a σ⁷⁰ promoter?
  3. Which enzyme makes the 5’–5’ linkage in the mRNA cap?
Answers
  1. U1 snRNA (later replaced by U6).
  2. TATAAT (Pribnow box).
  3. Guanylyltransferase (capping enzyme), transferring GMP from GTP to the 5’-diphosphate end.

Level 2: Part B Style

Q1 (practice). Isolated mammalian nuclei are incubated with labelled UTP and a low concentration of α-amanitin that inhibits only the most sensitive polymerase. Which RNA would still be labelled normally?

  • (a) pre-mRNA of a housekeeping gene
  • (b) pri-miRNA
  • (c) 45S pre-rRNA and pre-tRNA
  • (d) U2 snRNA
Answer and explanation

(c). A low concentration inhibits Pol II only. Pol I (45S pre-rRNA) and Pol III (tRNA) continue. Pre-mRNA, pri-miRNA and U2 snRNA are Pol II products.

Q2 (practice). In a group I self-splicing reaction in vitro, the first nucleophile is:

  • (a) the 2’-OH of an internal adenosine
  • (b) the 3’-OH of a free guanosine nucleotide or nucleoside
  • (c) the 3’-OH of the upstream exon
  • (d) a water molecule activated by Mg²⁺
Answer and explanation

(b). Exogenous G binds a pocket in the intron and its 3’-OH attacks the 5’ splice site. The upstream exon’s 3’-OH attacks in the second step (c). (a) describes group II and nuclear introns.

Q3 (practice). A point mutation changes the AAUAAA sequence in the 3’ UTR of a gene to AAGAAA. The most likely immediate effect is:

  • (a) failure of cap formation
  • (b) inefficient cleavage and polyadenylation, with reduced levels of mature mRNA
  • (c) retention of the first intron
  • (d) a frameshift in the protein
Answer and explanation

(b). AAUAAA is the CPSF-binding polyadenylation signal; the AAUAAA → AAGAAA change disrupts recognition, so 3’ end formation and termination are impaired and less mature, exported, stable mRNA is made. It is in the 3’ UTR, so the coding frame is unchanged.

Q4 (practice). A bacterial operon for lysine biosynthesis has a structured 5’ leader. Adding lysine to the medium causes premature termination of transcription within the leader in a purified system containing only DNA, RNA polymerase, NTPs and lysine. The leader most likely contains:

  • (a) an attenuator that depends on ribosome stalling
  • (b) a riboswitch
  • (c) a binding site for a lysine-activated repressor protein
  • (d) a group II intron
Answer and explanation

(b). No ribosomes and no regulatory protein are present, yet lysine acts directly on the nascent RNA: the aptamer binds lysine and favours a terminator. Attenuation (a) needs translating ribosomes; (c) needs a protein.

Level 3: Part C Style

Q1 (practice). RT-PCR with primers in exon 2 and exon 4 of a gene amplifies two products from brain RNA: 420 bp and 300 bp. Exon 3 is 120 bp. From liver RNA only the 420 bp product appears. Sequencing of the 420 bp product from brain shows a G at one position where the genomic DNA has an A. Which conclusions are justified?

(A) Exon 3 is alternatively skipped in brain. (B) The skipping preserves the reading frame. (C) The A → G difference most likely reflects ADAR editing. (D) Liver lacks the U2 snRNP.

  • (a) A, B and C
  • (b) A and D only
  • (c) B and C only
  • (d) A, B, C and D
Answer and worked solution

(a) A, B and C.

  • 420 − 300 = 120 bp = exon 3, so the shorter product lacks exon 3: exon skipping in brain (A).
  • 120 is divisible by 3 (120/3 = 40 codons), so skipping removes 40 amino acids without a frameshift (B).
  • Inosine is read as G by reverse transcriptase, so an A in DNA appearing as G in cDNA is the signature of A-to-I editing (C).
  • (D) is absurd: without U2 there would be no splicing at all, and liver clearly splices exons 2-3-4.

Q2 (practice). A 60 kb eukaryotic gene is transcribed by Pol II at 40 nt s⁻¹ (assume a constant rate). (i) How long does it take to transcribe the gene once? (ii) If transcription stops completely at time zero after flavopiridol addition, but polymerases already past the pause site continue, how long until the last polymerase finishes? (iii) A Drosophila gene has four alternative exon clusters containing 12, 48, 33 and 2 mutually exclusive alternatives. How many distinct mRNAs can, in principle, be made?

Answer and worked solution

(i) \(t = 60{,}000/40 = 1500\ \text{s} = 25\ \text{min}\).

(ii) Flavopiridol inhibits P-TEFb, so no new polymerase is released from the promoter-proximal pause; those already elongating continue. The last one released just before addition must travel nearly the full 60 kb: about 25 min. Measuring how the “wave” of loss moves along a gene after such a block is one way to estimate elongation rates.

(iii) Mutually exclusive choices multiply: \(12 \times 48 \times 33 \times 2 = 38{,}016\) mRNAs (this is the Dscam calculation).

Q3 (practice). In a reporter assay, a luciferase gene carries a 3’ UTR with a 7-nt sequence perfectly complementary to nucleotides 2–8 of an miRNA. Cells are co-transfected with the reporter and the miRNA (or a control). Results (relative luciferase activity; relative luciferase mRNA by qPCR):

ConditionActivitymRNA
Control RNA1.001.00
miRNA0.350.55
miRNA + reporter with seed site mutated0.981.02
siRNA fully complementary to a coding-region site0.100.08

Interpret the results.

Answer and worked solution
  • The miRNA represses the reporter through the seed site: mutating the site abolishes repression (0.98).
  • Repression involves both mRNA loss (0.55, consistent with deadenylation and decay) and reduced translation of the remaining mRNA: protein per mRNA = 0.35/0.55 ≈ 0.64.
  • The fully complementary siRNA reduces mRNA and activity in parallel (0.08 and 0.10; activity per mRNA ≈ 1.25, i.e. no extra translational effect): AGO2 slicing destroys the mRNA.
  • Conclusion: seed-matched animal miRNAs act by combined destabilisation and translational repression, whereas perfect complementarity gives cleavage.

Quick Revision Table

ItemFact
E. coli RNAPCore α₂ββ’ω + σ; rifampicin binds β
σ⁷⁰ promoter−35 TTGACA, −10 TATAAT, 17 bp spacer; UP element binds αCTD
σ⁵⁴−24/−12; needs ATP-driven enhancer-binding activator (NtrC)
TerminationIntrinsic: GC hairpin + U-run; Rho: rut site, ATP helicase
InhibitorsRifampicin (initiation, bacteria); actinomycin D (DNA, elongation, all); α-amanitin (Pol II > III > I); cordycepin (chain terminator); DRB/flavopiridol (CDK9)
Pol I / II / IIIrRNA 18S-5.8S-28S / mRNA, miRNA, most snRNA / tRNA, 5S, U6, 7SL
Pol II GTFsTFIID (TBP + TAFs), IIA, IIB, IIF, IIE, IIH (XPB helicase, CDK7)
CTDYSPTSPS repeats; Ser5-P initiation/capping; Ser2-P elongation/3’ end
ActivatorsModular DBD + AD; Mediator; co-activators HAT, remodellers
Capm⁷GpppN; 5’–5’ triphosphate; triphosphatase, guanylyltransferase, N7-MTase (SAM)
SplicingGU…A…AG; 2 transesterifications; lariat 2’–5’; U1, U2, U4/U6, U5
Self-splicingGroup I exogenous G, linear; group II branch A, lariat
NMDStop codon >50–55 nt upstream of last exon junction; EJC, UPF
EditingapoB C→U (APOBEC1), apoB-48 in intestine; A→I (ADAR) read as G
Poly(A)AAUAAA (CPSF) + GU-rich (CstF); PAP; histone mRNAs lack poly(A)
ExportmRNA NXF1 (Ran-independent); tRNA exportin-t; pre-miRNA exportin-5; CRM1 for NES and HIV Rev
snoRNAsC/D → 2’-O-methylation; H/ACA → pseudouridylation
RibozymesGroup I/II, RNase P, hammerhead/hairpin/HDV, rRNA peptidyl transferase, spliceosome, glmS
RiboswitchesAptamer + expression platform; TPP, FMN, SAM, Lys, Gly, purines; control termination or SD access
miRNA pathwayDrosha–DGCR8 → exportin-5 → Dicer → AGO; seed nt 2–8
piRNADicer-independent, PIWI, germline transposon silencing

Key Takeaways

What’s Next